Skip Navigation


Julie GoodmanJulie E. Goodman, PhD ‘02, ScM ’00

Distinguished Alumna Award

Principal, Gradient

Dr. Goodman is a Fellow of the American College of Epidemiology and of the Academy of Toxicological Sciences with expertise in assessing human health risks from chemicals in consumer products and the environment. After graduating from the Bloomberg School, she was a Cancer Prevention Fellow at the National Cancer Institute, working in the Laboratory of Human Carcinogenesis, where she conducted molecular epidemiology studies on colon cancer risk. She was also instrumental in the development of Polymorphism Interaction Analysis, a powerful statistical tool for cancer risk assessment.

Dr. Goodman is currently an adjunct faculty member in the Department of Epidemiology at the Harvard T.H. Chan School of Public Health and a Principal at Gradient, an environmental consulting firm. She has conducted a comprehensive critical weight-of-evidence review of the effects of very low exposures to bisphenol A on reproduction and development via endocrine disruption, which led to her testifying before several state legislative committees regarding potential restrictions on bisphenol A. She has made major contributions to public health by researching and developing weight-of-evidence methodologies that incorporate toxicology, epidemiology and mechanistic data, including the hypothesis-based weight-of-evidence approach.